Prior dengue virus exposure shapes T cell immunity to Zika virus in humans

Journal of Virology

Volumn 91, Issue 24, 2017, Pages

  Grifoni, Alba ^a   Pham, John ^a   Sidney, John ^a   O'Rourke, Patrick H ^a   Paul, Sinu ^a   Peters, Bjoern ^a   Martini, Sheridan R ^a   de Silva, Aruna D ^a,b   Ricciardi, Michael J ^c   Magnani, Diogo M ^c   Silveira, Cassia G T ^d   Maestri, Alvino ^d   Costa, Priscilla R ^d   de Oliveira Pinto, Luzia Maria ^e   de Azeredo, Elzinandes Leal ^e   Damasco, Paulo Vieira ^f   Phillips, Elizabeth ^g,t   Mallal, Simon ^g,t   de Silva, Aravinda M ^h   Collins, Matthew ^h   Durbin, Anna ⁱ   Diehl, Sean A ^j   Cerpas, Cristhiam ^k   Balmaseda, Angel ^k   Kuan, Guillermina ^k   Coloma, Josefina ^l   Harris, Eva ^l   Crowe, James E ^m   Stone, Mars ⁿ   Norris, Phillip J ⁿ   Busch, Michael ⁿ   Vivanco Cid, Hector ^o   Cox, Josephine ^p   Graham, Barney S ^p   Ledgerwood, Julie E ^p   Turtle, Lance ^q,r   Solomon, Tom ^q,s   Kallas, Esper G ^d   Watkins, David I ^c   Weiskopf, Daniela ^a   Sette, Alessandro ^a   more..

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Genetech Research Institute   (Sri Lanka)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^k Ministry of Health   (Nicaragua)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^o UNIVERSIDAD VERACRUZANA   (Mexico)

^p NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^q UNIVERSITY OF LIVERPOOL   (United Kingdom)

^r ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^s THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^t MURDOCH UNIVERSITY   (Australia)

more..

Author keywords

Cross reactivity; DENV; Heterologous immunity; Immunodominance; T cells; ZIKV

Indexed keywords

DENGUE VACCINE; GILVETMAB; GRANZYME B; VIRAL PROTEIN; VIRUS ANTIGEN; ZIKA VIRUS VACCINE; EPITOPE; LIVE VACCINE;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KINETICS; CELL SHAPE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CROSS REACTION; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; FEMALE; HEALTH CARE PLANNING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN STRUCTURE; UPREGULATION; VACCINATION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS IMMUNITY; VIRUS REPLICATION; ZIKA FEVER; ZIKA VIRUS; COHORT ANALYSIS; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS REACTIONS; DENGUE VACCINES; DENGUE VIRUS; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; VACCINES, ATTENUATED; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85035768097     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01469-17     Document Type: Article

References (55)

1. Fauci AS, Morens DM. 2016. Zika virus in the Americas-yet another arbovirus threat. N Engl J Med 374:601-604. https://doi.org/10.1056/NEJMp1600297
2. Heymann DL, Hodgson A, Sall AA, Freedman DO, Staples JE, Althabe F, Baruah K, Mahmud G, Kandun N, Vasconcelos PF, Bino S, Menon KU. 2016. Zika virus and microcephaly: why is this situation a PHEIC? Lancet 387:719-721. https://doi.org/10.1016/S0140-6736(16)00320-2
3. Rubin EJ, Greene MF, Baden LR. 2016. Zika virus and microcephaly. N Engl J Med 374:984-985. https://doi.org/10.1056/NEJMe1601862
4. Sikka V, Chattu VK, Popli RK, Galwankar SC, Kelkar D, Sawicki SG, Stawicki SP, Papadimos TJ. 2016. The emergence of Zika virus as a global health security threat: a review and a consensus statement of the INDUSEM joint working group (JWG). J Global Infect Dis 8:3-15. https://doi.org/10.4103/0974-777X.176140
5. Musso D, Gubler DJ. 2016. Zika virus. Clin Microbiol Rev 29:487-524. https://doi.org/10.1128/CMR.00072-15
6. Xu X, Vaughan K, Weiskopf D, Grifoni A, Diamond MS, Sette A, Peters B. 2016. Identifying candidate targets of immune responses in Zika virus based on homology to epitopes in other flavivirus species. PLoS Curr 8:ecurrents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
7. Yun SI, Lee YM. 2017. Zika virus: an emerging flavivirus. J Microbiol 55:204-219. https://doi.org/10.1007/s12275-017-7063-6
8. Pierson TC, Graham BS. 2016. Zika virus: immunity and vaccine development. Cell 167:625-631. https://doi.org/10.1016/j.cell.2016.09.020
9. Rivino L, Lim MQ. 2017. CD4+ and CD8+ T-cell immunity to dengue-lessons for the study of Zika virus. Immunology 150:146-154. https://doi.org/10.1111/imm.12681
10. Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A. 2013. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci U S A 110: E2046-E2053. https://doi.org/10.1073/pnas.1305227110
11. Weiskopf D, Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, De Silva AD, Phillips E, Mallal S, Premawansa S, Premawansa G, Wijewickrama A, Peters B, Sette A. 2016. HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses. J Infect Dis 214:1117-1124. https://doi.org/10.1093/infdis/jiw309
12. Weiskopf D, Sette A. 2014. T-cell immunity to infection with dengue virus in humans. Front Immunol 5:93. https://doi.org/10.3389/fimmu.2014.00093
13. Ahmed R, Akondy RS. 2011. Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines. Immunol Cell Biol 89: 340-345. https://doi.org/10.1038/icb.2010.155
14. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, Ahmed R. 2009. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol 183:7919-7930. https://doi.org/10.4049/jimmunol.0803903
15. Weiskopf D, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, de Silva AD, Lindow JC, Diehl SA, Whitehead S, Durbin A, Kirkpatrick B, Sette A. 2015. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol 89:120-128. https://doi.org/10.1128/JVI.02129-14
16. Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A. 2014. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. J Virol 88: 11383-11394. https://doi.org/10.1128/JVI.01108-14
17. World Health Organization. 2017. Zika virus, microcephaly and Guillain-Barré syndrome. World Health Organization, Geneva, Switzerland
18. Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Loriere E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA. 2016. Structural basis of potent Zika-dengue virus antibody crossneutralization. Nature 536:48-53. https://doi.org/10.1038/nature18938
19. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR. 2016. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol 17:1102-1108. https://doi.org/10.1038/ni.3515
20. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232-1239. https://doi.org/10.3201/eid1408.080287
21. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J. 2016. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 113:7852-7857. https://doi.org/10.1073/pnas.1607931113
22. Speer SD, Pierson TC. 2016. Virology. Diagnostics for Zika virus on the horizon. Science 353:750-751
23. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. 2016. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823-826. https://doi.org/10.1126/science.aaf8505
24. Sharma S, Thomas PG. 2014. The two faces of heterologous immunity: protection or immunopathology. J Leukoc Biol 95:405-416. https://doi.org/10.1189/jlb.0713386
25. Welsh RM, Che JW, Brehm MA, Selin LK. 2010. Heterologous immunity between viruses. Immunol Rev 235:244-266. https://doi.org/10.1111/j.0105-2896.2010.00897.x
26. Rothman AL. 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11:532-543. https://doi.org/10.1038/nri3014
27. de Alwis R, Bangs DJ, Angelo MA, Cerpas C, Fernando A, Sidney J, Peters B, Gresh L, Balmaseda A, de Silva AD, Harris E, Sette A, Weiskopf D. 2016. Immunodominant dengue virus-specific CD8+ T cell responses are associated with a memory PD-1+ phenotype. J Virol 90:4771-4779. https://doi.org/10.1128/JVI.02892-15
28. Weiskopf D, Cerpas C, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, Sanches FP, Silvera CG, Costa PR, Kallas EG, Gresh L, de Silva AD, Balmaseda A, Harris E, Sette A. 2015. Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets. J Infect Dis 212:1743-1751. https://doi.org/10.1093/infdis/jiv289
29. Wen J, Tang WW, Sheets N, Ellison J, Sette A, Kim K, Shresta S. 2017. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells. Nat Microbiol 2:17036. https://doi.org/10.1038/nmicrobiol.2017.36
30. Elong Ngono A, Chen HW, Tang WW, Joo Y, King K, Weiskopf D, Sidney J, Sette A, Shresta S. 2016. Protective role of cross-reactive CD8 T cells against dengue virus infection. EBioMedicine 13:284-293. https://doi.org/10.1016/j.ebiom.2016.10.006
31. Collins MH, McGowan E, Jadi R, Young E, Lopez CA, Baric RS, Lazear HM, de Silva AM. 2017. Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23:773-781. https://doi.org/10.3201/eid2305.161630
32. Zehn D, Turner MJ, Lefrancois L, Bevan MJ. 2010. Lack of original antigenic sin in recall CD8(+) T cell responses. J Immunol 184: 6320-6326. https://doi.org/10.4049/jimmunol.1000149
33. Pantoja P, Perez-Guzman EX, Rodriguez IV, White LJ, Gonzalez O, Serrano C, Giavedoni L, Hodara V, Cruz L, Arana T, Martinez MI, Hassert MA, Brien JD, Pinto AK, de Silva A, Sariol CA. 2017. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun 8:15674. https://doi.org/10.1038/ncomms15674
34. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy RS, Kissick HT, Nayak K, Reddy ES, Kalam H, Kumar D, Verma A, Panda H, Wang S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Medigeshi GR, Lodha R, Kabra S, Ahmed R, Murali-Krishna K. 2016. Characterization of human CD8 T cell responses in dengue virus-infected patients from India. J Virol 90:11259-11278. https://doi.org/10.1128/JVI.01424-16
35. Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, Kiely N, Kamel HT, Tobler LH, Busch MP, Norris PJ. 2008. Comprehensive analysis of West Nile virus-specific T cell responses in humans. J Infect Dis 197: 1296-1306. https://doi.org/10.1086/586898
36. Turtle L, Bali T, Buxton G, Chib S, Chan S, Soni M, Hussain M, Isenman H, Fadnis P, Venkataswamy MM, Satishkumar V, Lewthwaite P, Kurioka A, Krishna S, Shankar MV, Ahmed R, Begum A, Ravi V, Desai A, Yoksan S, Fernandez S, Willberg CB, Kloverpris HN, Conlon C, Klenerman P, Satchidanandam V, Solomon T. 2016. Human T cell responses to Japanese encephalitis virus in health and disease. J Exp Med 213:1331-1352. https://doi.org/10.1084/jem.20151517
37. Sips GJ, Wilschut J, Smit JM. 2012. Neuroinvasive flavivirus infections. Rev Med Virol 22:69-87. https://doi.org/10.1002/rmv.712
38. Domingues RB, Kuster GW, Onuki-Castro FL, Souza VA, Levi JE, Pannuti CS. 2008. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci 267:36-40. https://doi.org/10.1016/j.jns.2007.09.040
39. Soares CN, Cabral-Castro MJ, Peralta JM, Freitas MR, Puccioni-Sohler M. 2010. Meningitis determined by oligosymptomatic dengue virus type 3 infection: report of a case. Int J Infect Dis 14:e150-e152. https://doi.org/10.1016/j.ijid.2009.03.016
40. Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS. 2013. A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J Infect Dis 207:957-965. https://doi.org/10.1093/infdis/jis936
41. Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D. 2017. Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity. J Virol 91:e02147-16. https://doi.org/10.1128/JVI.02147-16
42. Kirkpatrick BD, Durbin AP, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Diehl SA, Elwood D, Jarvis AP, Sabundayo BP, Lyon CE, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS. 2015. Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults. J Infect Dis 212:702-710. https://doi.org/10.1093/infdis/jiv082
43. Kuan G, Gordon A, Aviles W, Ortega O, Hammond SN, Elizondo D, Nunez A, Coloma J, Balmaseda A, Harris E. 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170:120-129. https://doi.org/10.1093/aje/kwp092
44. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, Saborio SI, Mercado JC, Perez L, Videa E, Almanza E, Kuan G, Reyes M, Saenz L, Amador JJ, Harris E. 2006. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11:935-942. https://doi.org/10.1111/j.1365-3156.2006.01641.x
45. Fernandez RJ, Vazquez S. 1990. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz 85:347-351. https://doi.org/10.1590/S0074-02761990000300012
46. Waggoner JJ, Gresh L, Mohamed-Hadley A, Ballesteros G, Davila MJ, Tellez Y, Sahoo MK, Balmaseda A, Harris E, Pinsky BA. 2016. Singlereaction multiplex reverse transcription PCR for detection of Zika, chikungunya, and dengue viruses. Emerg Infect Dis 22:1295-1297. https://doi.org/10.3201/eid2207.160326
47. Waggoner JJ, Ballesteros G, Gresh L, Mohamed-Hadley A, Tellez Y, Sahoo MK, Abeynayake J, Balmaseda A, Harris E, Pinsky BA. 2016. Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and chikungunya virus detection. J Clin Virol 78:57-61. https://doi.org/10.1016/j.jcv.2016.01.007
48. Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, Sullivan NJ, Goudsmit J, Nabel GJ, Graham BS, VRC 205 Study Team. 2010. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 29:304-313. https://doi.org/10.1016/j.vaccine.2010.10.037
49. Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, Abeysinghe N, de-Silva AM, Gunasekera M. 2009. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 15:192-199. https://doi.org/10.3201/eid1502.080926
50. Kraus AA, Messer W, Haymore LB, de Silva AM. 2007. Comparison of plaque-and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol 45:3777-3780. https://doi.org/10.1128/JCM.00827-07
51. Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS. 2016. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7:e01123-16. https://doi.org/10.1128/mBio.01123-16
52. Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Pierro AM, Gaibani P, Guo FP, Sambri V, Balmaseda A, Karunaratne K, Harris E, Pinsky BA. 2013. Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis 7:e2116. https://doi.org/10.1371/journal.pntd.0002116
53. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui HH, Grey H, Sette A. 2006. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24:817-819. https://doi.org/10.1038/nbt1215
54. Paul S, Sidney J, Sette A, Peters B. 2016. TepiTool: a pipeline for computational prediction of T cell epitope candidates. Curr Protoc Immunol 114:18-24
55. Weiskopf D, Bangs DJ, Sidney J, Kolla RV, De Silva AD, de Silva AM, Crotty S, Peters B, Sette A. 2015. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci U S A 112:E4256-E4263. https://doi.org/10.1073/pnas.1505956112